Dipak Kotecha
Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design
Kotecha, Dipak; Manzano, Luis; Altman, Douglas G; Krum, Henry; Erdem, Guliz; Williams, Nicola; Flather, Marcus D; Beta-Blockers in Heart Failure Collaborative Group
Authors
Luis Manzano
Douglas G Altman
Henry Krum
Guliz Erdem
Nicola Williams
Marcus D Flather
Beta-Blockers in Heart Failure Collaborative Group
Contributors
Professor Alan Rigby A.Rigby@hull.ac.uk
Other
Abstract
The Beta-Blockers in Heart Failure Collaborative Group (BB-HF) was formed to obtain and analyze individual patient data from the major randomized controlled trials of beta-blockers in heart failure. Even though beta-blockers are an established treatment for heart failure, uptake is still sub-optimal. Further, the balance of efficacy and safety remains uncertain for common groups including older persons, women, those with impaired renal function and diabetes. Our aim is to provide clinicians with a thorough and definitive evidence-based assessment of these agents. We have identified 11 large randomized trials of beta-blockers versus placebo in heart failure and plan to meta-analyze the data on an individual patient level. In total, these trials have enrolled 18,630 patients. Uniquely, the BB-HF group has secured access to the individual data for all of these trials, with the participation of key investigators and pharmaceutical companies.Our principal objectives include deriving an overall estimate of efficacy for all-cause mortality and cardiovascular hospitalization. Importantly, we propose a statistically-robust sub-group assessment according to age, gender, diabetes and other key factors; analyses which are only achievable using an individual patient data meta-analysis. Further, we aim to provide an assessment of economic benefit and develop a risk model for the prognosis of patients with chronic heart failure.This paper outlines inclusion criteria, search strategies, outcome measures and planned statistical analyses. Clinical trial registration information: http://clinicaltrials.gov/ct2/show/NCT00832442.
Citation
Kotecha, D., Manzano, L., Altman, D. G., Krum, H., Erdem, G., Williams, N., …Beta-Blockers in Heart Failure Collaborative Group. (2013). Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design. Systematic reviews, 2(1), Article 7. https://doi.org/10.1186/2046-4053-2-7
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 3, 2012 |
Online Publication Date | Jan 18, 2013 |
Publication Date | 2013-12 |
Deposit Date | Mar 3, 2018 |
Publicly Available Date | Oct 27, 2022 |
Journal | Systematic reviews |
Print ISSN | 2046-4053 |
Electronic ISSN | 2046-4053 |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
Volume | 2 |
Issue | 1 |
Article Number | 7 |
DOI | https://doi.org/10.1186/2046-4053-2-7 |
Keywords | Beta-blockers; Heart failure; Meta-analysis; Design paper |
Public URL | https://hull-repository.worktribe.com/output/706408 |
Publisher URL | https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/2046-4053-2-7 |
Files
Article
(526 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/2.0
Copyright Statement
© Kotecha et al.; licensee BioMed Central Ltd. 2013<br />
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
You might also like
High-fidelity simulation and virtual reality: An evaluation of medical students' experiences
(2021)
Journal Article
Relation Between Thyroid Function and Mortality in Patients With Chronic Heart Failure
(2020)
Journal Article